https://www.selleckchem.com/pr....oducts/BafilomycinA1
ation date 3 April 2019, retrospectively registered. NCT03900559. Trial Registration date 3 April 2019, retrospectively registered. To evaluate the perceived usability of and user engagement with a digital platform (Thought Spot) designed to enhance mental health and wellness help-seeking among transition-aged youth (TAY; 17-29-years old). Survey responses and usage patterns were collected as part of a randomized controlled trial evaluating the efficacy of Thought Spot. Participants given Thought Spot completed an adapted Usefulne
Like
Comment
Share
